Botulinum toxin injections for new onset bilateral vocal fold motion impairment in adults

Department of Otolaryngology/Head and Neck Surgery, Mayo Clinic Rochester, Minnesota, USA.
The Laryngoscope (Impact Factor: 2.03). 04/2010; 120(4):758-63. DOI: 10.1002/lary.20821
Source: PubMed

ABSTRACT Review of clinical experience and results using botulinum toxin type A (BTX) for the management of adult patients with respiratory compromise due to new onset bilateral vocal fold motion impairment (BVFMI).
Retrospective case series.
The records of 11 patients from two institutions with respiratory compromise due to bilateral vocal fold motion impairment were reviewed. Age, sex, etiology of motion impairment, subjective response to BTX injections, changes in pulmonary function studies pre- and postinjection when available, the dosage of botulinum toxin required to achieve response, the number of injections per patient, and complications were reported.
All patients were over 18 years old. There were three male and eight female subjects. The etiology of BVFMI was due to previous anterior cervical surgery in nine patients and prolonged intubation in two. Ten patients reported symptomatic improvement and returned for an average of nine injections over the 10-year period of study. The most common interval between injections was 3 months. In all patients the dose required to achieve symptomatic improvement was at least 2.5 mouse units injected into each vocal fold. One patient without relief of symptoms had bilateral cricoarytenoid joint fixation. Complications were limited to moderate dysphagia in one patient and breathy dysphonia in all patients.
BTX injection into the vocal folds provides temporary relief of symptoms in airway obstruction in adult patients with BVFMI. Patients require an average of 2.5 units of botulinum injection into each vocal fold and have an average length of response of 3 months. BTX injection may be used as a form of temporary relief of airway obstruction in patients wishing to avoid ablative surgery or tracheotomy.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Eine bilaterale Stimmlippenparese mit Paramedianstellung der Stimmlippen kann infolge von iatrogenen oder traumatischen Nervenverletzungen, neurologischen Erkrankungen und extralaryngealen Malignomen auftreten und führt bei den Betroffenen meist zu erheblicher Atemnot, während die Stimme kaum beeinträchtigt ist. Nur etwa 10% dieser Patienten können die durch eine bilaterale Stimmbandparese bedingte Atemwegsverengung im Alltag tolerieren; bei den meisten Patienten ist eine operative Intervention notwendig. Heute steht eine Reihe intraluminärer Verfahren zur Glottiserweiterung bei bilateralem Stimmbandstillstand zur Verfügung, welche eine Tracheotomie primär vermeiden oder langfristig überflüssig machen sollen und aufwendige extralaryngeale Zugänge zur Glottis von außen weitgehend ersetzt haben. Der vorliegende Beitrag soll einen Überblick über die wichtigsten intraluminären Operationen bei bilateraler Stimmlippenparese geben und erläutert ausführlich Indikationsstellung, operatives Vorgehen, Vorteile und potenzielle Risiken der dargestellten Verfahren zur temporären oder permanenten Glottiserweiterung. Bilateral vocal fold paralysis with paramedian position of the vocal chords can result from iatrogenic or traumatic nerve injuries, neurologic disorders and extralaryngeal malignancies and usually causes significant shortness of breath while the voice is only slightly affected. Only about 10% of the affected patients tolerate the narrowed airway caused by bilateral vocal fold paralysis in adduction, so most patients are candidates for a surgical intervention. Today, a range of intraluminal surgical procedures for enlargement of the glottis in bilateral vocal fold paralysis have been described which intend to avoid or supersede tracheostomy and which have replaced time-consuming external approaches to the glottis. This report provides an overview of the most important intraluminal surgical procedures for bilateral vocal fold paralysis in adduction and comments in detail on indications, surgical techniques, advantages and potential complications of the presented procedures for temporary or definitive enlargement of the glottis. SchlüsselwörterBilaterale Stimmbandparese–Atemnot–Glottiserweiterung–Chirurgische Techniken–Laser KeywordsBilateral vocal fold paralysis–Dyspnoea–Glottic enlargement–Surgical techniques–Laser
    Der Chirurg 01/2011; 82(2):116-124. DOI:10.1007/s00104-010-1973-8 · 0.52 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: IMPORTANCE More than half of children with bilateral vocal fold paralysis require a tracheostomy for airway management. We report an innovative, minimally invasive approach consisting of onabotulinum toxin A injection into the cricothyroid muscles. OBSERVATIONS Onabotulinum toxin A was injected under direct vision into the cricothyroid muscles of 6 pediatric patients with bilateral abductor vocal fold paralysis. None of the patients had fold fixation on laryngoscopy performed at the time of the injection. All patients had a documented increase in airway patency as visualized on flexible laryngoscopy within days after injection. This procedure successfully averted a tracheostomy in 5 patients and permitted decannulation of the sixth patient. CONCLUSIONS AND RELEVANCE Onabotulinum toxin A injection into the cricothyroid muscles leads to an increase in the glottic space, providing an adequate airway. Onabotulinum toxin A injection in the cricothyroid muscles could be offered as a safe, effective, noninvasive first-line option for patients with bilateral vocal fold paralysis.
    08/2014; 140(9). DOI:10.1001/jamaoto.2014.1515
  • [Show abstract] [Hide abstract]
    ABSTRACT: Botulinum toxin injections are an effective treatment option for several laryngeal disorders. This article reviews the indications, procedural techniques, potential complications, and outcomes of Botox injections for laryngeal disorders.
    Otolaryngologic Clinics of North America 02/2013; 46(1):53-61. DOI:10.1016/j.otc.2012.08.017 · 1.34 Impact Factor